Edward T. Richardson

Also affiliated with Merck & Co., Inc., Rahway, NJ, USA (United States)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer”.

Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005119

N/A

1.2DataRank · unranked

39 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Gerburg M. Wulf, Edward T. Richardson +10 more

Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-23-1711

N/A

0.596DataRank · unranked

15 citations

Yingtian Xie, Shira Sherman, Zsuzsanna Nagy, Douglas Russo, Tara Akhshi +36 more

Retinoblastoma protein expression and its predictors in triple-negative breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-0160-4

N/A

0DataRank · unranked

47 citations

Andrew J. Goss, Judy E. Garber, Vanda F. Torous, Edward T. Richardson, Miriam J. Haviland +9 more

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study

npj Breast Cancer(2021)10.1038/s41523-021-00287-9

N/A

0DataRank · unranked

51 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo Pastorello +11 more

NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift

Modern Pathology(2023)10.1016/j.modpat.2023.100144

N/A

0DataRank · unranked

24 citations

Pier Selenica, Fresia Pareja, Paola dal Cin, Etta Hanlon, Britta Weigelt +5 more

885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0885

N/A

0DataRank · unranked

1 citations

Filipa Lynce, Xue Geng, Edward T. Richardson, Candace Mainor, Mei Wei +14 more